BioScreening - Bioscreening Company Directory - Grants and Funding
(http://grants.nih.gov/grants/guide/pa-files/PAR-12-058.html)
Government Agencies and Organizations Solicitation of Assays for High
Throughput Screening (HTS) to Discover Chemical Probes (R01)
(http://grants.nih.gov/grants/guide/pa-files/PAR-12-058.html) National
Institute of Health Funding Opportunities
(http://grants.nih.gov/grants/guide/index.html) NIH Small Business
Funding Opportunities (http://grants1.nih.gov/grants/funding/sbir.htm)
SBIR Coach (http://www.SBIRcoach.com) and SBIR Resource Center
(http://www.sbir.gov/) Community of Science (COS) Funding
Opportunities (http://fundingopps2.cos.com/) The National Institute of
Standards and Technology (NIST) Funding Opportunities
(http://www.nist.gov/director/ocfo/grants/grants.cfm) Department of
Defense Funding Opportunities
(http://cdmrp.army.mil/funding/default.shtml) US Department of Health
and Human Services Qualifying Therapeutic Discovery Project Program
(http://grants.nih.gov/grants/funding/QTDP_PIM/index.htm#qualifying)
Non-government Agences and Foundations The Bill Melinda Gates
Foundation Grant Opportunities
(http://www.gatesfoundation.org/grantseeker/Pages/overview.aspx) The
Michael J. Fox Foundation for Parkinson’s Research
(http://www.michaeljfox.org/research.cfm) Multiple Myeloma Research
Foundation (MMRF)
(http://www.themmrf.org/research-programs/for-academic-researchers/)
John Templeton Foundation
(http://www.templeton.org/what_we_fund/2010_funding_priorities/)
Google Ventures (http://www.googleventures.com/) Venture Capital Firms
Domain Associates (http://www.domainvc.com/) Founded in 1985, Domain
Associates, L.L.C. is a venture capital firm with an exclusive focus
on life sciences. With $2.5 billion of capital under management,
Domain is headquartered in Princeton, NJ with a second office in San
Diego, CA. Domain’s three major investment segments are
pharmaceuticals, specialty pharmaceuticals, and medical devices, while
additional areas of interest include biomaterials, bioinstrumentation,
and diagnostics. The Partners of Domain have a total of close to 200
person-years of experience among them in the healthcare/venture
capital industries and have been involved in the formation and growth
of more than 220 life-sciences companies. The highly focused network,
experience, and reputation of this team have made it one of the top
private-equity groups participating in the healthcare field.
HealthCare Ventures (http://www.hcven.com/) HealthCare Ventures is a
leading life science venture capital firm investing in pre-clinical or
early clinical stage, project-focused companies with potential to
transform patient care. HCV approach is to identify high potential
products within academia or pharmaceutical companies, develop them to
clinical proof-of-concept within capital efficient, semi-virtual
organizations, and generate superior returns through acquisitions by
pharmaceutical and biotechnology companies Polaris Venture Partners
(http://www.polarisventures.com/) Polaris Venture Partners is a
partnership of experienced venture capital investors and technology
executives. Our mission is to identify and invest in seed, first
round, and early stage technology and life science businesses with
exceptional promise and help them grow into sustainable,
market-leading companies. In addition, Polaris is committed to
providing growth equity and shareholder liquidity to established
companies in the technology, healthcare, manufacturing, media,
communications, and business services sectors. As a national venture
capital firm with offices in the high-tech centers of Boston and
Seattle, we’re able to invest in businesses throughout the United
States and around the world. The firm has over $3 billion under
management and current investments in more than 100 companies. MPM
Capital (http://www.mpmcapital.com/) MPM Capital is one of the world's
largest life science-dedicated venture investors. With committed
capital under management in excess of $2 billion, MPM Capital is
uniquely structured to invest globally in healthcare innovation. Alta
Partners (http://www.altapartners.com/) Alta Partners is a leading
venture capital firm in life sciences, funding over 130 companies in
the industry since 1996. The diverse and integrated team brings
together a powerful depth of knowledge and experience, delivering
tangible results for our companies and our investors. Alta is
committed to building successful businesses through deep collaborative
partnerships with outstanding entrepreneurs. Alta invests only in
those areas where it has specific domain expertise. ARCH
(http://www.archventure.com/) ARCH invests primarily in companies
co-founded with leading scientists and entrepreneurs, concentrating on
bringing to market innovations in life sciences, physical sciences,
and information technology. The firm enjoy special recognition as a
leader in the successful commercialization of technologies developed
at academic research institutions and national laboratories. Flagship
Ventures (http://www.flagshipventures.com/) Flagship Ventures is a
venture capital firm focused on creating, financing and building
innovative companies. Founded in 2000, Flagship manages over $600
million in early-stage funds and operates from its offices at Kendall
Square in Cambridge, MA. With an active portfolio of over 40
companies, the firm’s strategy is to balance its investments across
three principal business sectors: Therapeutics, Life Science Tools
Diagnostics, and BioEnergy/Cleantech. SV Life Sciences
(http://www.svlsa.com/) SV Life Sciences is a leading international
life sciences venture capital firm. SVLS affiliated funds have been
investing in life sciences companies since the early 1980s and the
firm closed its first dedicated life sciences fund in 1994. The SVLS
team manages six venture capital funds and a publicly traded
investment trust with approximately $2 billion of capital under
management. The firm employs a diversified strategy within life
sciences in order to selectively capitalize on an expanding
opportunity in biotech, medical devices and health-care services. SVLS
has offices in Boston, London and San Francisco. Sanderling
(http://www.sanderling.com/) Founded in 1979, Sanderling is among the
oldest investment firms dedicated to building new biomedical
companies. Sanderling demonstrates that significant companies are best
built in close working partnerships with entrepreneurs. Sanderling's
unique approach combines a specialized investment focus with active
management and long-term commitment to ensure the highest rates of
return for both its entrepreneurs and investors. Biomedical investing
has been a viable sector in the technology markets for more than
thirty years, and in the past ten years has experienced accelerated
growth. Since its inception, Sanderling has supported over 90
biomedical companies from very early stage start-ups, through
commercial development, earning consistently high rates of return on
its venture investments. Kleiner Perkins Caufield Byers
(http://www.kpcb.com/) Kleiner Perkins Caufield Byers are passionately
committed to helping their portfolio companies succeed. Entrepreneurs
gain access to their matched portfolio of companies and associations
with global business leaders. These relationships are the foundation
for strategic alliances, partnership opportunities and the sharing of
insights to help build new ventures faster, broader and with less
risk. InterWest Partners (http://www.interwest.com/) For more than 30
years InterWest has partnered with exceptional entrepreneurs to build
winning technology and life sciences companies. With more than 200
years of combined operating and investing experience, our team has
raised $2.8B, completed more than 70 IPOs, and participated in nearly
60 upside acquisitions. As we invest InterWest X, a $650M fund,
Partners continue to believe that providing capital is just the
beginning of a long-term collaboration with entrepreneurs to turn
their vision into a thriving company. Sofinnova Ventures
(http://www.sofinnova.com/) Sofinnova Ventures has over 30 years of
experience building start-ups and spin-outs into market leaders. With
$1 billion under management, the firm applies capital and expertise to
guide early stage companies to successful exits. Burrill Venture
Capital (http://www.burrillandco.com/) The Burrill family of venture
capital funds includes funds with more than $950 million under
management. These funds were formed to capitalize on Burrill’s
unique investment platform and the opportunities created by today’s
intersection of the genomic/proteomic and biologic revolution, and
capital market inefficiency occurring within the life science field.
New Enterprise Associates (http://www.nea.com/) For more than 30
years, NEA has been helping to build great companies. NEA’s
committed capital has grown to $11 billion and it’s funded more than
650 companies in the Information Technology, Energy Technology and
Healthcare sectors. With more than 65 investment professionals working
out of offices in the US, India, and China and investing across the
globe—NEA is the entrepreneur's venture capital firm, consistently
ranking among the top firms in portfolio IPOs each year. Since its
founding, the firm has backed more than 165 companies that have gone
public and invested in more than 255 companies that have been
successfully merged or acquired—more liquidity events than any other
venture capital firm. OrbiMed (http://www.orbimed.com/) OrbiMed is the
world's largest healthcare-dedicated investment firm, with
approximately $5 billion in assets under management. OrbiMed's
investment advisory business was founded in 1989 with a vision to
invest across the spectrum of healthcare companies: from private
start-ups to large multinational companies. OrbiMed manages the
Caduceus Private Investments series of venture capital funds and a
family of public equity investment funds. OrbiMed's investment team
includes over 35 experienced professionals with backgrounds in
science, medicine, industry, finance, information technology and law.
Quaker BioVentures (http://www.quakerbio.com/) Quaker BioVentures is a
venture capital firm investing in life science companies. The firm
leads investments across the spectrum of the life science industry,
including biopharmaceuticals, medical devices, human diagnostics,
specialty pharmaceuticals, and healthcare services. Quaker BioVentures
invests in companies at all stages of development, from early stage
start-ups to public companies. Founded in 2003, the firm is currently
investing Quaker BioVentures II, a $420 million fund formed in 2007.
Quaker BioVentures manages over $700 million in committed capital.
Venrock (http://www.venrock.com/) Venrock was founded in 1969 as the
venture capital arm of the Rockefeller Family and we have $2.2 billion
under management. Venrock provides funding and services for
entrepreneurs with breakthrough ideas in technology, healthcare, media
and energy. Venrock's entrepreneurs have charted new advancements in
cancer and HIV treatments, powered semiconductors and the digital era,
secured our information technology infrastructure, pioneered on-line
advertising, delighted consumers and most recently, generating power
through alternative means. Venrock's 22 investment professionals
currently back 117 ventures out of offices in Palo Alto, New York
City, Cambridge, and Israel. SciFiles (http://sciflies.org/) SciFlies
is a new model for funding scientific research that allows the general
public to get involved in scientific research by making small
donations resulting in financing research for projects just waiting to
prove new ideas that work, but just lack the funding to get started.
SciFlies is a qualified nonprofit and all donations are
tax-deductible. FundScience (http://apply.fundscience.org/)
FundScience is an online charitable organization, which aims to create
an open platform for funding the research of promising young
scientists. Its mission is to generate start-up funding for pilot
projects while raising public awareness of basic research. Above
leading venture capital firms focusing on life-science R D according
to FierceBiotech listing. More venture companies: Aberdare Ventures
(http://www.aberdare.com) Abingworth (http://www.abingworth.com) Aeris
CAPITAL (http://www.aeris-capital.com/) Aisling Capital
(http://www.aislingcapital.com/) Anthem Capital
(http://www.anthemcapital.com) Alliance Technology Ventures
(http://www.alliancetechventures.com/) Apple Tree Partners
(http://www.appletreepartners.com/) Avalon Ventures
(http://www.avalon-ventures.com/) Edmond de Rothschild Investment
Partners (http://www.edmond-de-rothschild.fr) Bay City Capital
(http://www.baycitycapital.com/) Bessemer Venture Partners
(http://www.bvp.com/) Care Capital (http://www.carecapital.com/)
Caxton Advantage Life Sciences Fund (http://www.caxtonadvantage.com/)
Chicago Growth Partners (http://www.cgp.com) Clarus Ventures
(http://www.clarusventures.com) DAG Ventures
(http://www.dagventures.com/) Delphi Ventures
(http://www.delphiventures.com/) Devon Park Bioventures
(http://www.dpbioventures.com) Enterprise Partners Venture Capital
(http://www.epvc.com) Essex Woodlands Health Ventures
(http://www.essexwoodlands.com/) Excel Medical Fund
(http://www.emven.com) Forbion Capital Partners
(http://www.forbion.com/) Frazier Healthcare Ventures
(http://www.frazierhealthcare.com) Grupo Cornelio Brennand
(http://www.grupocorneliobrennand.com.br) HBM BioCapital
(http://www.hbmpartners.com) Highland Capital Partners
(http://www.hcp.com) Intersouth Partners (http://www.intersouth.com)
Khosla Ventures (http://www.khoslaventures.com) McNerney Partners
(http://www.tm-partners.com) MDV-Mohr Davidow Ventures
(http://www.mdv.com/) Morningside Venture (http://www.morningside.com)
MVM Life Science Partners (http://www.mvmlifescience.com) Northgate
Capital (http://www.northgatecapital.com) Novo A/S
(http://www.novo.dk) Osage Partners (http://www.osagepartners.com) OVP
Venture Partners (http://www.ovp.com) Oxford Finance Corporation
(http://www.oxfordfinance.com) Panorama Capital
(http://www.panoramacapital.com) ProQuest Investments
(http://www.proquestvc.com) Prospect Venture Partners
(http://www.prospectventures.com) Rho Capital Partners
(http://www.rho.com) Scale Venture Partners (http://www.scalevp.com)
Sectoral Asset Management (http://www.sectoral.com) SR One, the
corporate venture fund of GlaxoSmithKline
(http://www.gsk.com/collaborations/srone.htm) Sutter Hill Ventures
(http://www.shv.com) Teachers' Private Capital (http://www.otpp.com)
The Column Group (http://www.thecolumngroup.net) TPG Biotech
(http://www.tpgbiotech.com/) Venrock Associates
(http://www.venrock.com) Versant Ventures
(http://www.versantventures.com) Votorantim Novos Negocios
(http://www.votorantim.com.br) Wellcome Trust
(http://www.wellcome.ac.uk) Ysios Capital Partners
(http://www.ysioscapital.com)